Search results for: Phill O’Neill
Filter search results
OHE at ISPOR Philadelphia: Presentations and Posters
4 June 2015
…in line with Clinical Practice’ Health Technology Assessment Decisions ISPOR poster ri lwcp 140515 from Office of Health Economics Phill O’Neill (OHE), Amanda Cole (OHE, presenting author), Nancy Devlin (OHE),…
Recently Published: New Report Comparing Usage of Medicines in the UK with Other Countries
6 January 2015
…for the ABPI by Phill O’Neill and Jon Sussex of the Office of Health Economics. They have estimated the quantities of medicines used per head of population in the UK…
OHE at ISPOR Europe: Posters
13 November 2014
The OHE presented the following posters at ISPOR 17th Annual European Congress in Amsterdam, The Netherlands. Ispor measuring access_pon_nd from Office of Health Economics Phill O’Neill and Nancy Devlin …
NICE Decisions: Exploring the Influence of Cost-Effectiveness and Other Factors
30 April 2013
…OHE’s Prof Nancy Devlin and Helen Dakin of the University of Oxford, the seminar discussed research recently completed by them in collaboration with OHE’s Yan Feng and Phill O’Neill, Nigel…
Incentives for New Drugs and Vaccines to Tackle Anti-Microbial Resistance
16 May 2017
…the Market Entry Reward should be further explored for use in Europe as a regional “pull” incentive. The new OHE Briefing looks at the proposals in the 2016 O’Neill Report,…
An Analysis of NICE’s Optimised Decisions from 2015 to 2024
1 May 2025
Share this: Download publication Brittany Darrow Sulayman Chowdhury Phill O’Neill Nadine Henderson The National Institute for Health and Care Excellence (NICE) is the body responsible for recommending medicines for use…
Just Released: Health and the Use of Medicines in Wales
3 November 2011
…savings to help increase the timely uptake of recommended medicines. For further information, please contact Lesley Baillie or Phill O’Neill at OHE. Download Baillie, L., Hawe, E., O’Neill, P. and…
How Restrictive are NICE ‘Optimised’ Decisions?
27 April 2023
…access was developed by OHE researchers (O’Neill and Devlin, 2010). It was further utilised in our 2020 report looking at NICE decisions from 2015 to 2019 (Bulut et al., 2020)….
Rare Disease Day 2024: Why Do We Care About Rare?
29 February 2024
…Therapies Being Achieved?; 2023. https://www.ohe.org/publications/recommendations-for-hta-of-gene-therapies-being-achieved/ OHE. Challenges and Facilitators in the Development of Orphan and Paediatric Medicines.; 2022. https://www.ohe.org/wp-content/uploads/2022/02/challenges-and-facilitators-in-the-development-of-orphan-and-paediatric-medicines.pdf Zamora B, Maignen F, O’Neill P, Mestre-Ferrandiz J, Garau M. Comparing…